Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2
ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), is a recently emerged respiratory coronavirus that has infected >23 million people worldwide with >800,000 deaths. Few COVID-19 therapeutics are available, and the basis for...
Enregistré dans:
| Auteurs principaux: | Idoia Busnadiego, Sonja Fernbach, Marie O. Pohl, Umut Karakus, Michael Huber, Alexandra Trkola, Silke Stertz, Benjamin G. Hale |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
American Society for Microbiology
2020
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/fa5798cc3bce4c0196b825fcd06ded1e |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Killing Two Birds with One Stone by Administration of Soluble ACE2: A Promising Strategy to Treat Both Cardiovascular Diseases and SARS-CoV-2 Infection
par: Fengling Feng, et autres
Publié: (2021) -
Measurement of serum ACE status may potentially improve the diagnosis of SARS-CoV-2 infection
par: Gcinokwakhe D Ngcobo
Publié: (2021) -
PDZ-Containing Proteins Targeted by the ACE2 Receptor
par: Célia Caillet-Saguy, et autres
Publié: (2021) -
A Plausible Link of TMPRSS2/ACE2/AR Signaling to Male Mortality during the COVID-19 Pandemic in the United States
par: Lilly M. Wong, et autres
Publié: (2021) -
Presencia y Expresión del Receptor ACE2 (Target de SARS-CoV-2) en Tejidos Humanos y Cavidad Oral. Posibles Rutas de Infección en Órganos Orales
par: Pastrian-Soto,Gabriel
Publié: (2020)